HomeCompareMIUFF vs MRK

MIUFF vs MRK: Dividend Comparison 2026

MIUFF yields 3.50% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MIUFF wins by $172.6K in total portfolio value
10 years
MIUFF
MIUFF
● Live price
3.50%
Share price
$7.50
Annual div
$0.26
5Y div CAGR
47.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$230.3K
Annual income
$106,615.93
Full MIUFF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — MIUFF vs MRK

📍 MIUFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMIUFFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MIUFF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MIUFF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MIUFF
Annual income on $10K today (after 15% tax)
$297.76/yr
After 10yr DRIP, annual income (after tax)
$90,623.54/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, MIUFF beats the other by $82,026.83/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MIUFF + MRK for your $10,000?

MIUFF: 50%MRK: 50%
100% MRK50/50100% MIUFF
Portfolio after 10yr
$144.0K
Annual income
$58,364.86/yr
Blended yield
40.53%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

MIUFF
No analyst data
Altman Z
0.7
Piotroski
5/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MIUFF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMIUFFMRK
Forward yield3.50%2.81%
Annual dividend / share$0.26$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR47.4%32.7%
Portfolio after 10y$230.3K$57.7K
Annual income after 10y$106,615.93$10,113.78
Total dividends collected$196.2K$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MIUFF vs MRK ($10,000, DRIP)

YearMIUFF PortfolioMIUFF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,216$516.35$11,213$373.04+$3.00MIUFF
2$12,799$797.83$12,667$512.06+$132.00MIUFF
3$14,949$1,254.18$14,439$708.14+$510.00MIUFF
4$18,014$2,017.96$16,640$988.16+$1.4KMIUFF
5$22,625$3,349.72$19,432$1,394.07+$3.2KMIUFF
6$30,004$5,795.55$23,057$1,992.90+$6.9KMIUFF
7$42,692$10,587.78$27,889$2,894.79+$14.8KMIUFF
8$66,434$20,753.31$34,518$4,286.29+$31.9KMIUFF
9$115,572$44,488.07$43,912$6,494.35+$71.7KMIUFF
10$230,278$106,615.93$57,714$10,113.78+$172.6KMIUFF

MIUFF vs MRK: Complete Analysis 2026

MIUFFStock

Mitsubishi HC Capital Inc., together with its subsidiaries, engages in the lease, installment sale, and other financing activities in Japan, North America, Europe, the Middle and Near East, Asia/Oceania, and internationally. The company operates through Customer Business, Account Solution, Vendor Solution, LIFE, Real Estate, Environment & Renewable Energy, Aviation, Logistics, Mobility, and Others segments. It offers finance solutions for corporations, government agencies, and vendors; provides sales finance through collaboration with vendors; develops, operates, and leases logistics and commercial facilities; and engages in the community development, food, agriculture, living essentials industry, and non-life insurance businesses. The company also offers real estate securitization finance, as well as engages in the real estate investment, asset management, and leasing activities; and power generation through renewable energy, as well as provision of environment-related equipment leasing and financing services. In addition, it provides aircraft, aircraft engine, marine container, railway freight car, and auto leasing services; and medical equipment leasing and finance, and social infrastructure investment and finance services. Further, the company offers trust and settlement services. Mitsubishi HC Capital Inc. was incorporated in 1971 and is based in Tokyo, Japan.

Full MIUFF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this MIUFF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MIUFF vs SCHDMIUFF vs JEPIMIUFF vs OMIUFF vs KOMIUFF vs MAINMIUFF vs JNJMIUFF vs ABBVMIUFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.